Polyclonal Antibody to Apolipoprotein A1 (APOA1)
Référence MBS2001457-0,1mL
Conditionnement : 0.1mL
Marque : MyBiosource
Apolipoprotein A1 (APOA1) Antibody – Rabbit Polyclonal
For Research Use Only. Not for use in diagnostic procedures. Special Promotion Catalog #: MBS2001457SPECIAL PROMOTION: Get FREE Starbucks gift card (Maximum 5 gift cards/product). Gift card(s) will be included with shipment
MBS2001457 is an antibody targeting APOA1. Also known as Polyclonal Antibody to Apolipoprotein A1 (APOA1). Reactive in Goat. Host: Rabbit. More details
Product Overview
Online Datasheet in PDFProduct Name
Apolipoprotein A1 (APOA1), Polyclonal Antibody
Full Product Name
Polyclonal Antibody to Apolipoprotein A1 (APOA1)
Product Gene Name
anti-APOA1 antibody
Clonality
Polyclonal
Host
Rabbit
Species Reactivity
Goat
Form/Format
Supplied as solution form in PBS, pH7.4, containing 0.02% NaN3,50% glycerol.
Purity/Purification
Affinity Chromatography
Concentration
500ug/mL (lot specific)
Specificity
The antibody is a rabbit polyclonal antibody raised against APOA1. It has been selected for its ability to recognize APOA1 in immunohistochemical staining andwestern blotting.
Preparation and Storage
Store at 4 degree C for frequent use. Stored at -20 degree C to -80 degree C in a manual defrost freezer for one year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
Matching Pairs
Unconjugated Antibody: APOA1 (MBS2001457)
Biotin Conjugated Antibody: APOA1 (MBS2002895)
Biotin Conjugated Antibody: APOA1 (MBS2002895)
Matching Pairs
Unconjugated Antibody: APOA1 (MBS2001457)
APC-CY7 Conjugated Antibody: APOA1 (MBS2043245)
APC-CY7 Conjugated Antibody: APOA1 (MBS2043245)
Molecular Weight
30,778 Da
Chromosome Location
Chromosome: 11; NC_000011.9 (116706467..116708338, complement). Location: 11q23-q24
OMIM
105200
Supply Chain Verification
Manufactured in a lab with traceable raw materials. Bulk orders can typically be prepared to the customer’s specifications, please inquire.
ISO Certification
Manufactured in an ISO 9001:2015 and ISO 13485:2016 Certified Laboratory.
Applications Tested/Suitable for anti-APOA1 antibody
Immunocytochemistry (ICC), Immunohistochemistry (IHC) - Formalin/Paraffin, ELISA (EIA), Western Blot (WB)
Application Notes for anti-APOA1 antibody
Western blotting: 1:100-400
Immunocytochemistry in formalin fixed cells: 1:100-500
Immunohistochemistry in formalin fixed frozen section: 1:100-500
Immunohistochemistry in paraffin section: 1:50-200
Enzyme-linked Immunosorbent Assay: 1:100-200
Immunocytochemistry in formalin fixed cells: 1:100-500
Immunohistochemistry in formalin fixed frozen section: 1:100-500
Immunohistochemistry in paraffin section: 1:50-200
Enzyme-linked Immunosorbent Assay: 1:100-200
Other Notes
Small volumes of anti-APOA1 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Additional Details
NCBI/Uniprot data below describe general gene information for APOA1. It may not necessarily be applicable to this product.
NCBI Official Full Name
apolipoprotein A1
NCBI Official Synonym Full Names
apolipoprotein A-I
NCBI Official Symbol
APOA1
UniProt Protein Name
Apolipoprotein A-I
UniProt Synonym Protein Names
Apolipoprotein A1Cleaved into the following chain:Truncated apolipoprotein A-I; Alternative name(s):; Apolipoprotein A-I(1-242)
Protein Family
Apolipoprotein
UniProt Gene Name
APOA1
UniProt Synonym Gene Names
Apo-AI; ApoA-I
UniProt Entry Name
APOA1_HUMAN
NCBI Protein Information
apolipoprotein A-I; apo-AI
NCBI Summary for APOA1
This gene encodes apolipoprotein A-I, which is the major protein component of high density lipoprotein (HDL) in plasma. The protein promotes cholesterol efflux from tissues to the liver for excretion, and it is a cofactor for lecithin cholesterolacyltransferase (LCAT) which is responsible for the formation of most plasma cholesteryl esters. This gene is closely linked with two other apolipoprotein genes on chromosome 11. Defects in this gene are associated with HDL deficiencies, including Tangier disease, and with systemic non-neuropathic amyloidosis. [provided by RefSeq, Jul 2008]
Show more UniProt Comments for APOA1
APOA1: Participates in the reverse transport of cholesterol from tissues to the liver for excretion by promoting cholesterol efflux from tissues and by acting as a cofactor for the lecithin cholesterol acyltransferase (LCAT). As part of the SPAP complex, activates spermatozoa motility. Interacts with APOA1BP and CLU. Component of a sperm activating protein complex (SPAP), consisting of APOA1, an immunoglobulin heavy chain, an immunoglobulin light chain and albumin. Interacts with NDRG1. Major protein of plasma HDL, also found in chylomicrons. Synthesized in the liver and small intestine. The oxidized form at Met-110 and Met-136 is increased in individuals with increased risk for coronary artery disease, such as in carrier of the eNOSa/b genotype and exposure to cigarette smoking. It is also present in increased levels in aortic lesions relative to native ApoA-I and increased levels are seen with increasing severity of disease. Belongs to the apolipoprotein A1/A4/E family.
Protein type: Secreted; Cell development/differentiation; Lipid-binding; Endoplasmic reticulum; Secreted, signal peptide; Vesicle; Motility/polarity/chemotaxis
Chromosomal Location of Human Ortholog: 11q23-q24
Cellular Component: extracellular space; chylomicron; cell surface; endoplasmic reticulum lumen; endocytic vesicle; early endosome; plasma membrane; extracellular region; cytoplasmic vesicle; cytosol; nucleus; vesicle
Molecular Function: identical protein binding; lipase inhibitor activity; beta-amyloid binding; cholesterol binding; phosphatidylcholine binding; high-density lipoprotein binding; protein binding; enzyme binding; phospholipid transporter activity; cholesterol transporter activity; chemorepellent activity; phospholipid binding; apolipoprotein A-I receptor binding; apolipoprotein receptor binding
Biological Process: phototransduction, visible light; negative chemotaxis; negative regulation of lipase activity; axon regeneration in the peripheral nervous system; sequestering of lipid; negative regulation of interleukin-1 beta secretion; regulation of cholesterol absorption; transforming growth factor beta receptor signaling pathway; positive regulation of stress fiber formation; response to drug; cholesterol metabolic process; platelet activation; organ regeneration; regulation of Cdc42 protein signal transduction; adrenal gland development; positive regulation of hydrolase activity; positive regulation of Rho protein signal transduction; lipoprotein metabolic process; positive regulation of transferase activity; vitamin transport; cholesterol biosynthetic process; negative regulation of cytokine secretion during immune response; cholesterol homeostasis; response to estrogen stimulus; lipoprotein biosynthetic process; peptidyl-methionine modification; phosphatidylcholine biosynthetic process; positive regulation of lipoprotein lipase activity; blood vessel endothelial cell migration; cellular lipid metabolic process; platelet degranulation; phospholipid efflux; retinoid metabolic process; transmembrane transport; response to nutrient; phospholipid homeostasis; integrin-mediated signaling pathway; receptor-mediated endocytosis; positive regulation of fatty acid biosynthetic process; regulation of protein amino acid phosphorylation; cholesterol transport; negative regulation of heterotypic cell-cell adhesion; protein amino acid oxidation; protein stabilization; neurite regeneration; cholesterol efflux; G-protein coupled receptor protein signaling pathway; glucocorticoid metabolic process; reverse cholesterol transport; endothelial cell proliferation; negative regulation of inflammatory response; blood coagulation
Disease: Hypoalphalipoproteinemia, Primary; Amyloidosis, Familial Visceral
Show more Protein type: Secreted; Cell development/differentiation; Lipid-binding; Endoplasmic reticulum; Secreted, signal peptide; Vesicle; Motility/polarity/chemotaxis
Chromosomal Location of Human Ortholog: 11q23-q24
Cellular Component: extracellular space; chylomicron; cell surface; endoplasmic reticulum lumen; endocytic vesicle; early endosome; plasma membrane; extracellular region; cytoplasmic vesicle; cytosol; nucleus; vesicle
Molecular Function: identical protein binding; lipase inhibitor activity; beta-amyloid binding; cholesterol binding; phosphatidylcholine binding; high-density lipoprotein binding; protein binding; enzyme binding; phospholipid transporter activity; cholesterol transporter activity; chemorepellent activity; phospholipid binding; apolipoprotein A-I receptor binding; apolipoprotein receptor binding
Biological Process: phototransduction, visible light; negative chemotaxis; negative regulation of lipase activity; axon regeneration in the peripheral nervous system; sequestering of lipid; negative regulation of interleukin-1 beta secretion; regulation of cholesterol absorption; transforming growth factor beta receptor signaling pathway; positive regulation of stress fiber formation; response to drug; cholesterol metabolic process; platelet activation; organ regeneration; regulation of Cdc42 protein signal transduction; adrenal gland development; positive regulation of hydrolase activity; positive regulation of Rho protein signal transduction; lipoprotein metabolic process; positive regulation of transferase activity; vitamin transport; cholesterol biosynthetic process; negative regulation of cytokine secretion during immune response; cholesterol homeostasis; response to estrogen stimulus; lipoprotein biosynthetic process; peptidyl-methionine modification; phosphatidylcholine biosynthetic process; positive regulation of lipoprotein lipase activity; blood vessel endothelial cell migration; cellular lipid metabolic process; platelet degranulation; phospholipid efflux; retinoid metabolic process; transmembrane transport; response to nutrient; phospholipid homeostasis; integrin-mediated signaling pathway; receptor-mediated endocytosis; positive regulation of fatty acid biosynthetic process; regulation of protein amino acid phosphorylation; cholesterol transport; negative regulation of heterotypic cell-cell adhesion; protein amino acid oxidation; protein stabilization; neurite regeneration; cholesterol efflux; G-protein coupled receptor protein signaling pathway; glucocorticoid metabolic process; reverse cholesterol transport; endothelial cell proliferation; negative regulation of inflammatory response; blood coagulation
Disease: Hypoalphalipoproteinemia, Primary; Amyloidosis, Familial Visceral
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Product Note
Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.
Product PubMed Publications
Products associated with anti-APOA1 antibody
| Reference Product | PubMed Publications |
|---|---|
| APOB antibody | >434 publications with APOA1 and APOB |
| ABCA1 antibody | >110 publications with APOA1 and ABCA1 |
| APOC3 antibody | >60 publications with APOA1 and APOC3 |
| CETP antibody | >49 publications with APOA1 and CETP |
| APOA2 antibody | >35 publications with APOA1 and APOA2 |
| LCAT antibody | >35 publications with APOA1 and LCAT |
| ALB antibody | >7 publications with APOA1 and ALB |
| TTR antibody | >5 publications with APOA1 and TTR |
| FGA antibody | >1 publications with APOA1 and FGA |
Pathways associated with anti-APOA1 antibody
| Products by Pathway | Pathway Diagram |
|---|---|
| ABC-family Proteins Mediated Transport Pathway antibodies | ABC-family Proteins Mediated Transport Pathway Diagram |
| ABCA Transporters In Lipid Homeostasis Pathway antibodies | ABCA Transporters In Lipid Homeostasis Pathway Diagram |
| African Trypanosomiasis Pathway antibodies | African Trypanosomiasis Pathway Diagram |
| African Trypanosomiasis Pathway antibodies | African Trypanosomiasis Pathway Diagram |
| Amyloids Pathway antibodies | Amyloids Pathway Diagram |
| Binding And Uptake Of Ligands By Scavenger Receptors Pathway antibodies | Binding And Uptake Of Ligands By Scavenger Receptors Pathway Diagram |
| Chylomicron-mediated Lipid Transport Pathway antibodies | Chylomicron-mediated Lipid Transport Pathway Diagram |
| Disease Pathway antibodies | Disease Pathway Diagram |
| Diseases Associated With Visual Transduction Pathway antibodies | Diseases Associated With Visual Transduction Pathway Diagram |
| FOXA2 And FOXA3 Transcription Factor Networks Pathway antibodies | FOXA2 And FOXA3 Transcription Factor Networks Pathway Diagram |
Diseases associated with anti-APOA1 antibody
| Disease Name | Pubmed Publications |
|---|---|
| Cardiovascular Diseases Antibodies | >392 publications with APOA1 and Cardiovascular Diseases |
| Atherosclerosis Antibodies | >238 publications with APOA1 and Atherosclerosis |
| Dyslipidemias Antibodies | >168 publications with APOA1 and Dyslipidemias |
| Hyperlipidemias Antibodies | >121 publications with APOA1 and Hyperlipidemias |
| Inflammation Antibodies | >86 publications with APOA1 and Inflammation |
| Insulin Resistance Antibodies | >85 publications with APOA1 and Insulin Resistance |
| Hypertension Antibodies | >68 publications with APOA1 and Hypertension |
| Hypercholesterolemia Antibodies | >57 publications with APOA1 and Hypercholesterolemia |
| Hypertriglyceridemia Antibodies | >55 publications with APOA1 and Hypertriglyceridemia |
| Myocardial Infarction Antibodies | >44 publications with APOA1 and Myocardial Infarction |
Organs/Tissues associated with anti-APOA1 antibody
| Organ/Tissue Name | Pubmed Publications |
|---|---|
| Blood Antibodies | >706 publications with APOA1 and Blood |
| Liver Antibodies | >148 publications with APOA1 and Liver |
| Heart Antibodies | >135 publications with APOA1 and Heart |
| Muscle Antibodies | >30 publications with APOA1 and Muscle |
| Brain Antibodies | >25 publications with APOA1 and Brain |
| Ovary Antibodies | >13 publications with APOA1 and Ovary |
| Lung Antibodies | >12 publications with APOA1 and Lung |
| Intestine Antibodies | >10 publications with APOA1 and Intestine |
| Pancreas Antibodies | >6 publications with APOA1 and Pancreas |
| Embryonic Tissue Antibodies | >3 publications with APOA1 and Embryonic Tissue |


